These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
298 related articles for article (PubMed ID: 17464364)
1. Dynamic changes in Histone H3 lysine 9 acetylation localization patterns during neuronal maturation require MeCP2. Thatcher KN; LaSalle JM Epigenetics; 2006; 1(1):24-31. PubMed ID: 17464364 [TBL] [Abstract][Full Text] [Related]
2. Novel alterations in the epigenetic signature of MeCP2-targeted promoters in lymphocytes of Rett syndrome patients. Lilja T; Wallenborg K; Björkman K; Albåge M; Eriksson M; Lagercrantz H; Rohdin M; Hermanson O Epigenetics; 2013 Mar; 8(3):246-51. PubMed ID: 23348913 [TBL] [Abstract][Full Text] [Related]
3. MECP2 truncating mutations cause histone H4 hyperacetylation in Rett syndrome. Wan M; Zhao K; Lee SS; Francke U Hum Mol Genet; 2001 May; 10(10):1085-92. PubMed ID: 11331619 [TBL] [Abstract][Full Text] [Related]
4. Histone modifications in Rett syndrome lymphocytes: a preliminary evaluation. Kaufmann WE; Jarrar MH; Wang JS; Lee YJ; Reddy S; Bibat G; Naidu S Brain Dev; 2005 Aug; 27(5):331-9. PubMed ID: 16023547 [TBL] [Abstract][Full Text] [Related]
5. Setdb1-mediated histone H3K9 hypermethylation in neurons worsens the neurological phenotype of Mecp2-deficient mice. Jiang Y; Matevossian A; Guo Y; Akbarian S Neuropharmacology; 2011 Jun; 60(7-8):1088-97. PubMed ID: 20869373 [TBL] [Abstract][Full Text] [Related]
6. Stimulation of the Serotonin Receptor 7 Restores Brain Histone H3 Acetylation and MeCP2 Corepressor Protein Levels in a Female Mouse Model of Rett Syndrome. Napoletani G; Vigli D; Cosentino L; Grieco M; Talamo MC; Lacivita E; Leopoldo M; Laviola G; Fuso A; d'Erme M; De Filippis B J Neuropathol Exp Neurol; 2021 Feb; 80(3):265-273. PubMed ID: 33598674 [TBL] [Abstract][Full Text] [Related]
7. MeCP2 deficiency is associated with reduced levels of tubulin acetylation and can be restored using HDAC6 inhibitors. Gold WA; Lacina TA; Cantrill LC; Christodoulou J J Mol Med (Berl); 2015 Jan; 93(1):63-72. PubMed ID: 25209898 [TBL] [Abstract][Full Text] [Related]
8. Histone H3 and H4 modification profiles in a Rett syndrome mouse model. Urdinguio RG; Pino I; Ropero S; Fraga MF; Esteller M Epigenetics; 2007; 2(1):11-4. PubMed ID: 17965622 [TBL] [Abstract][Full Text] [Related]
9. Reciprocal co-regulation of EGR2 and MECP2 is disrupted in Rett syndrome and autism. Swanberg SE; Nagarajan RP; Peddada S; Yasui DH; LaSalle JM Hum Mol Genet; 2009 Feb; 18(3):525-34. PubMed ID: 19000991 [TBL] [Abstract][Full Text] [Related]
10. MeCP2 expression and function during brain development: implications for Rett syndrome's pathogenesis and clinical evolution. Kaufmann WE; Johnston MV; Blue ME Brain Dev; 2005 Nov; 27 Suppl 1():S77-S87. PubMed ID: 16182491 [TBL] [Abstract][Full Text] [Related]
11. MECP2 mutations in Rett syndrome adversely affect lymphocyte growth, but do not affect imprinted gene expression in blood or brain. Balmer D; Arredondo J; Samaco RC; LaSalle JM Hum Genet; 2002 Jun; 110(6):545-52. PubMed ID: 12107440 [TBL] [Abstract][Full Text] [Related]
12. Rett syndrome-causing mutations compromise MeCP2-mediated liquid-liquid phase separation of chromatin. Wang L; Hu M; Zuo MQ; Zhao J; Wu D; Huang L; Wen Y; Li Y; Chen P; Bao X; Dong MQ; Li G; Li P Cell Res; 2020 May; 30(5):393-407. PubMed ID: 32111972 [TBL] [Abstract][Full Text] [Related]
13. Deficiency of methyl-CpG binding protein-2 in CNS neurons results in a Rett-like phenotype in mice. Chen RZ; Akbarian S; Tudor M; Jaenisch R Nat Genet; 2001 Mar; 27(3):327-31. PubMed ID: 11242118 [TBL] [Abstract][Full Text] [Related]
14. Inhibitors of differentiation (ID1, ID2, ID3 and ID4) genes are neuronal targets of MeCP2 that are elevated in Rett syndrome. Peddada S; Yasui DH; LaSalle JM Hum Mol Genet; 2006 Jun; 15(12):2003-14. PubMed ID: 16682435 [TBL] [Abstract][Full Text] [Related]
15. X-Chromosome inactivation ratios affect wild-type MeCP2 expression within mosaic Rett syndrome and Mecp2-/+ mouse brain. Braunschweig D; Simcox T; Samaco RC; LaSalle JM Hum Mol Genet; 2004 Jun; 13(12):1275-86. PubMed ID: 15115765 [TBL] [Abstract][Full Text] [Related]
16. Quantitative localization of heterogeneous methyl-CpG-binding protein 2 (MeCP2) expression phenotypes in normal and Rett syndrome brain by laser scanning cytometry. LaSalle JM; Goldstine J; Balmer D; Greco CM Hum Mol Genet; 2001 Aug; 10(17):1729-40. PubMed ID: 11532982 [TBL] [Abstract][Full Text] [Related]
17. Epigenetic overlap in autism-spectrum neurodevelopmental disorders: MECP2 deficiency causes reduced expression of UBE3A and GABRB3. Samaco RC; Hogart A; LaSalle JM Hum Mol Genet; 2005 Feb; 14(4):483-92. PubMed ID: 15615769 [TBL] [Abstract][Full Text] [Related]
18. MeCP2 binds to non-CG methylated DNA as neurons mature, influencing transcription and the timing of onset for Rett syndrome. Chen L; Chen K; Lavery LA; Baker SA; Shaw CA; Li W; Zoghbi HY Proc Natl Acad Sci U S A; 2015 Apr; 112(17):5509-14. PubMed ID: 25870282 [TBL] [Abstract][Full Text] [Related]
19. MeCP2, A Modulator of Neuronal Chromatin Organization Involved in Rett Syndrome. Martínez de Paz A; Ausió J Adv Exp Med Biol; 2017; 978():3-21. PubMed ID: 28523538 [TBL] [Abstract][Full Text] [Related]
20. Exploring the possible link between MeCP2 and oxidative stress in Rett syndrome. Filosa S; Pecorelli A; D'Esposito M; Valacchi G; Hajek J Free Radic Biol Med; 2015 Nov; 88(Pt A):81-90. PubMed ID: 25960047 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]